We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography (ATAC)

This study is currently recruiting participants.
Verified January 2017 by Sunil Srivastava, The Cleveland Clinic
Sponsor:
ClinicalTrials.gov Identifier:
NCT01746537
First Posted: December 11, 2012
Last Update Posted: January 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Sunil Srivastava, The Cleveland Clinic
  Purpose
A prospective, observational, case series investigating the feasibility of utilizing OCT scans of the anterior chamber of eyes with uveitis.

Condition
Uveitis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Automated Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

Resource links provided by NLM:


Further study details as provided by Sunil Srivastava, The Cleveland Clinic:

Primary Outcome Measures:
  • Use the OCT to objectively image and grade the degree of anterior chamber inflammation in eyes with inactive and active uveitis. [ Time Frame: one year ]

Estimated Enrollment: 1500
Study Start Date: June 2012
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with inactive and active uveitis.
Criteria

Inclusion Criteria:

  • All patients presenting to Cole Eye Institute with uveitis.

Exclusion Criteria:

  • Inability to provide informed consent, including non-English speaking and cognitively/mentally impaired.
  • Severe corneal opacities preventing imaging of anterior chamber
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01746537


Contacts
Contact: Sunil K Srivastava, M.D. 216-636-2286
Contact: Kimberly M Baynes, BSN, RN 216-44-2566

Locations
United States, Ohio
Cole Eye Institute Recruiting
Cleveland, Ohio, United States, 44195
Contact: Sunil K Srivastava, M.D.    216-636-2286      
Contact: Kimberly M Baynes, BSN,RN    216-444-2566      
Principal Investigator: Sunil K Srivastava, M.D.         
Sponsors and Collaborators
The Cleveland Clinic
Investigators
Principal Investigator: Sunil K Srivastva, MD The Cleveland Clinic
  More Information

Responsible Party: Sunil Srivastava, Medical Doctor, The Cleveland Clinic
ClinicalTrials.gov Identifier: NCT01746537     History of Changes
Other Study ID Numbers: 12-612
First Submitted: December 7, 2012
First Posted: December 11, 2012
Last Update Posted: January 11, 2017
Last Verified: January 2017

Additional relevant MeSH terms:
Inflammation
Uveitis
Pathologic Processes
Uveal Diseases
Eye Diseases